Both in Biotechnology
ImmunityBio vs Kodiak Sciences
Over the past year IBRX returned +266.6% and KOD returned +432.4%; their daily moves had a correlation of 0.11.
IBRX +266.6% KOD +432.4%Growth of $1, one year, split-adjusted
| Metric | IBRX | KOD |
|---|---|---|
| Price | $8.29 | $98.82 |
| Market cap | $8.78B | $6.21B |
| Today | +4.21% | +1.22% |
| 1 month | −20.2% | +5.3% |
| 6 months | +9.3% | +131.6% |
| Year to date | +318.4% | +253.4% |
| 1 year | +245.2% | +445.2% |
| Revenue growth (YoY) | +93.9% | — |
| Gross margin | 99.4% | — |
| Net margin | −449.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 53.0× | — |
| Net cash | -$57.7M | $125.9M |
| Dividend yield | — | — |
| Volatility (60d) | 68.4% | 216.8% |
| Short % of float | 31.2% | 28.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).